Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

QR Code

Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

None

Enregistré dans:

Détails bibliographiques
Auteur principal:	Wenya, Wang
Format:	Électronique Chapitre de livre
Langue:	anglais
Publié:	IntechOpen 2011
Sujets:	Health Sciences
Accès en ligne:	https://www.intechopen.com/chapters/22883
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
par: Kayed, Rakez
Publié: (2011)

The Potential of Neurotrophic Factors for the Treatment of Parkinson’s Disease
par: Sullivan, Aideen M., et autres
Publié: (2011)

Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics
par: Marco Agostini, et autres
Publié: (2025-06-01)

Hypergravity and ERK Inhibition Combined Synergistically Reduce Pathological Tau Phosphorylation in a Neurodegenerative Cell Model
par: Valerio Mignucci, et autres
Publié: (2025-07-01)

Therapeutic Potential of Polyphenols in Parkinson’s Disease
par: Mythri, Rajeswara Babu, et autres
Publié: (2011)

Dopaminergic Control of the Neurotransmitter Release in the Subthalamic Nucleus: Implications for Parkinson’s Disease Treatment Strategies
par: Ampe, Ben, et autres
Publié: (2011)

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease
par: Bogatkevich, Galina S., et autres
Publié: (2012)

Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways
par: Cunha-Oliveira, Teresa, et autres
Publié: (2012)

Genetics of Parkinson Disease
par: Sassi, Celeste
Publié: (2011)

Parkin and Parkinson’s Disease
par: Tay, Shiam-Peng, et autres
Publié: (2011)

Update in Parkinson’s Disease
par: Carrillo, Fátima, et autres
Publié: (2012)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
par: Toni T. Saari, et autres
Publié: (2025-04-01)

The Execution Step in Parkinson’s Disease – On the Vicious Cycle of Mitochondrial Complex I Inhibition, Iron Dishomeostasis and Oxidative Stress
par: Núñez, Marco T., et autres
Publié: (2012)

CFS Biomarkers in Parkinson’s Disease
par: Parnetti, Lucilla, et autres
Publié: (2011)

Imaging Dyskinesias in Parkinson’s Disease
par: Politis, Marios, et autres
Publié: (2011)

Cognitive Dysfunction in Parkinson’s Disease
par: Varanese, Sara, et autres
Publié: (2011)

Gastrointestinal Dysfunction in Parkinson’s Disease
par: Krogh, Klaus
Publié: (2011)

Etiology and Pathogenesis of Parkinson’s Disease
par: Hatano, Taku, et autres
Publié: (2011)

Gene Therapy for Parkinson’s Disease
par: Douglas, Michael, et autres
Publié: (2011)

Timing Control in Parkinson’s Disease
par: Almeida, Quincy J.
Publié: (2012)

Parkinson’s Disease and the Immune System
par: Ward1, Roberta J., et autres
Publié: (2012)

Role of FKBPs in Parkinson’s Disease
par: Chattopadhaya, Souvik, et autres
Publié: (2012)

Dopamine Transporter Imaging for Distinguishing Between Idiopathic Parkinson’s Disease and Secondary Parkinsonism
par: Huang, Chin-Chang, et autres
Publié: (2012)

Wading into a Theoretical Model for Parkinson's Disease
par: Verzi, Diana W.
Publié: (2012)

Diagnosis and Differential Diagnosis of Parkinson’s Disease
par: Lingor, Paul, et autres
Publié: (2011)

How to Stay Active with Parkinson’s Disease
par: Qutubuddin, Abu
Publié: (2011)

Cognition and Gait Disturbances in Parkinson's Disease
par: Ribarič, Samo
Publié: (2011)

Nocturnal Disturbances in Patients with Parkinson’s Disease
par: Suzuki, Keisuke, et autres
Publié: (2011)

Neuropsychological Deficits in Initial Parkinson’s Disease
par: Fernandez, Raquel Rodriguez, et autres
Publié: (2011)

Cognitive and Psychiatric Aspects of Parkinson’s Disease
par: Stephani, Caspar
Publié: (2011)

The Negative Impact of Apathy in Parkinson’s Disease
par: Leroi, Iracema
Publié: (2011)

Analysis of Transcriptome Alterations in Parkinson’s Disease
par: Filatova, Elena, et autres
Publié: (2011)

Inflammatory Responses and Regulation in Parkinson’s Disease
par: Peterson, Lynda J., et autres
Publié: (2011)

Successes of Modelling Parkinson Disease in Drosophila
par: Staveley, Brian E.
Publié: (2012)

Acetyl-L-Carnitine in Parkinson’s Disease
par: Sinicropi, Maria Stefania, et autres
Publié: (2012)

Inflammation in Parkinson’s Disease: Causes and Consequences
par: Collins, Louise M., et autres
Publié: (2012)

Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease
par: García-Sierra, Francisco, et autres
Publié: (2011)

The Noradrenergic System is a Major Component in Parkinson’s Disease
par: Szot, Patricia, et autres
Publié: (2011)

The Energy Crisis in Parkinson’s Disease: A Therapeutic Target
par: Abou-Hamdan, Mhamad, et autres
Publié: (2011)

Botulinum A Toxin Intravesical Injections in the Treatment of Refractory Overactive Bladder in Patients with Parkinson's Disease
par: Giannantoni, Antonella, et autres
Publié: (2011)